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To understand the assembly and functional outcomes of protein-RNA regulation, it is crucial 
to precisely identify the positions of such interactions. Crosslinking and immunoprecipitation 
(CLIP) serves this purpose by exploiting covalent protein-RNA crosslinking and RNA 
fragmentation, along with a series of stringent purification and quality control steps to 
prepare cDNA libraries for sequencing. Here we describe the core steps of CLIP, its primary 
variations and the approaches to data analysis. We present the application of CLIP to 
studies of specific cell types in genetically engineered mice, and discuss the mechanistic 
and physiologic insights that have already been gained from studies employing CLIP. We 
conclude by discussing the future opportunities for CLIP, including studies of human 
postmortem tissues from disease patients and controls, RNA epigenetic modifications, and 
RNA structure. These and other applications of CLIP will continue to unravel fundamental 







A crucial step in understanding RNA-related gene regulation and its relationship to disease 
is identifying how RNAs are bound and hence regulated by RNA binding proteins (RBPs) in 
specific cell types and subcellular compartments. Driving our interest in this topic has been 
the growing list of human neurologic diseases that have RNA dysregulation at their core 
(Conlon and Manley 2017).  The first method developed for this purpose used antibodies 
against the spliceosomal Sm proteins (lupus autoimmune sera) to identify the small nuclear 
RNAs, which interact with Sm proteins within the abundant snRNPs (Lerner and Steitz 
1979). This method, later referred to as RIP (for RNP/RNA immunoprecipitation), relies on 
immunoprecipitation (IP) of an RBP under conditions that preserve ribonucleoprotein 
complexes (RNPs) (Niranjanakumari et al. 2002). However, RIP can suffer from low 
specificity, partly because it preserves protein-protein interactions and can therefore purify 
multiple RBPs in complex with their bound RNAs, and partly because RNA-protein 
complexes can reassociate in vitro (Mili and Steitz 2004).  
To understand the assembly of RNPs, a method to identify direct protein-RNA interactions 
with high specificity was required. Moreover, it was important to also identify the positions on 
RNAs that are recognized by a specific RBP in order to identify the RNA sequences and 
structures where regulation takes place. We have developed crosslinking and 
immunoprecipitation (CLIP) for this purpose by exploiting zero-length covalent protein-RNA 
crosslinking and RNA fragmentation, along with a series of stringent purification and quality 
control steps, followed by the preparation of a cDNA library for sequencing (Ule et al. 2003; 
R. B. Darnell 2010). With CLIP, only RNA fragments that are crosslinked to the specific RBP 
are isolated under well-optimized conditions, which avoid co-purification of additional RBPs. 
CLIP data can be validated with the use of appropriate negative controls, such as the use of 
cells or tissue that lack the RBP of interest or have not been crosslinked (Donny D. Licatalosi 
and Darnell 2010). CLIP is now generally accepted as a highly reliable method for identifying 
the positions of endogenous RNA-protein interactions (Conlon and Manley 2017).   
Initially, CLIP relied on Sanger sequencing to identify 340 sequences corresponding to RNA 
interactions of splicing factors Nova1 and Nova2 in mouse brain (Ule et al. 2003). In spite of 
the limited number of these initial sequences, many were located next to alternative exons 
that turned out to be regulated by Nova proteins, thus demonstrating the capacity of CLIP to 
identify functionally important binding sites. Subsequent development of HITS-CLIP (high-
throughput sequencing of RNA isolated by CLIP) was then applied to further studies of the 
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functional interactions of Nova and several other RBPs with neuronal transcripts in the 
mouse brain (D. D. Licatalosi et al. 2008; R. B. Darnell 2013). 
This work established a general strategy to link functional studies with a transcriptome-wide 
map of protein-RNA interactions. Such maps validated regulatory rules that had been 
bioinformatically predicted, in which the position of binding of RBPs within primary transcripts 
largely determines the outcome of RNA regulation (Ule et al. 2006; D. D. Licatalosi et al. 
2008; Donny D. Licatalosi and Darnell 2010).  These rules are now recognized as a general 
feature of pre-mRNA processing, applicable to dozens of different RBPs (Witten and Ule 
2011). Following these approaches, CLIP has been applied to a large number of different 
RBPs in a variety of cell types, organs and species. 
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The CLIP method 
 
Figure 1: The core steps of CLIP  
The steps A-E are common across most variants of CLIP. Methods that identify the sites of 
RNA methylation crosslink purified RNA to an antibody specific to a methylated base, as in 
m6A-CLIP, and then proceed from step C onwards. The first option to prepare the cDNA 
library is as in HITS-CLIP (F1), where the cDNA library is prepared by ligating an adapter to 
the 5’ end of RNA to allow amplification and sequencing of readthrough cDNAs, but not 
truncated cDNAs. The second option is as in iCLIP (F2), where adapter is ligated to the 3’ 
end of cDNAs, which allows amplification of both readthrough and truncated cDNAs (only a  
truncated cDNA is shown here, since this type most often represents >90% of the iCLIP 
cDNA library (Haberman et al. 2017; Sugimoto et al. 2012). The unique molecular identifiers 
(UMI) and experimental barcodes, which are introduced in iCLIP during reverse 
transcription, are color coded in green and violet. The RNA fragments and their 
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corresponding cDNA inserts are in grey. The figure is adapted based on previous publication 
by Lee and Ule (Lee and Ule 2018). 
 
The fundamentals 
Many variant protocols of CLIP have been derived during the last decade. Their detailed 
variations have been reviewed elsewhere (Lee and Ule 2018; R. B. Darnell 2010), and 
therefore we will focus here only on the primary steps that are common to most protocols 
(Figure 1). A feature common to all protocols is that RBPs are crosslinked by ultraviolet (UV) 
light to their bound RNAs within the intact endogenous environment. Acutely harvested cells, 
triturated or pulverized tissues, or even whole organisms such as C. elegans are 
immediately exposed to UV light, which crosslinks RBPs to their bound RNAs in their native 
(intracellular) state. We have adopted use of the term “CLIP” as a general way to refer to all 
protocols that use UV crosslinking and protein purification of directly bound native RNA-
protein complexes.  
Most CLIP variants exploit the capacity of UV light to promote formation of covalent bonds 
between RBPs and their direct RNA binding sites (Table S1). Unlike formaldehyde 
crosslinking that is used in chromatin immunoprecipitation (ChIP) and some variants of RIP, 
UV does not crosslink proteins to each other. UV crosslinking requires direct (Angstrom) 
contact between an amino acid and a nucleobase, and therefore ensures that only direct 
protein-RNA interactions are preserved. The high strength of the covalent bond allows a 
stringent buffer containing ionic detergents to be used for cell lysis, which disrupts most non-
crosslinked protein-protein and protein-RNA interactions. The stringent buffer also increases 
the accessibility of RNA for RNase fragmentation and minimizes the chance of co-purifying 
multiple associated RBPs during later immunoprecipitation, thus increasing data specificity. 
RNA fragmentation is crucial to avoid co-purifying multiple RBPs that crosslink to the same 
RNAs, and to provide insight into the position of RNA binding sites, since the RNA fragment 
contains the crosslink site. A well-optimized RNase concentration is important to minimize 
the constraints at the sites of RNase cleavage, which can lead to biased binding site 
assignment (Haberman et al. 2017). 
Purification of endogenous (i.e., untagged) RBPs normally requires that antibodies are 
available for efficient immunoprecipitation. The need for stringent purification and quality 
control varies to some extent on the type and expression of the RBP being studied, but in 
general this improves signal to noise of detection of directly bound RNAs. Some RBPs 
participate in stable RNPs that may not efficiently dissociate under standard CLIP 
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immunoprecipitation conditions, thus increasing their risk of co-purifying multiple RBPs, and 
careful protocols have articulated how to optimize the stringency of CLIP IPs (see (R. Darnell 
2012). Even a minor co-purification of an abundant RBP that crosslinks with high efficiency 
can lead to a major loss of specificity if the RBP-of-interest is of low abundance or crosslinks 
poorly. In such cases, RBPs can be epitope-tagged to allow purification under denaturing 
conditions (Granneman et al. 2009; Huppertz et al. 2014). With epitope-tagging, it is 
important to avoid overexpression, which can give artificial binding to unnatural RNA 
partners, and to test if the function, stability and localization of the tagged RBP remain 
unperturbed. 
To prepare cDNA libraries from the CLIP RNA fragments, an adapter is ligated to the 3’ end 
of the RNA. The sequence of the adapter is complementary to the primers that are later 
used in reverse transcription (RT) and PCR. This is followed by purification of the protein-
RNA complexes with the use of SDS-PAGE and membrane transfer. Both steps reduce the 
contamination of non-crosslinked RNAs and excess adapters, which normally run at a lower 
molecular weight in the gel than fragments crosslinked to the RBP; moreover, free 
(contaminating) RNA doesn’t bind well to the membrane. The labelled protein-RNA complex 
can be visualized on the membrane, serving to optimize RNA fragmentation and to control 
for the specificity of purified complexes. Labelling can be achieved radioactively with 32P on 
the 5’ end of the RNA (Ule et al. 2003) or the adapter (Chi et al. 2009), or by covalently 
coupling an infrared dye to the adapter, which allows visualization with infrared imaging 
(irCLIP) (Zarnegar et al. 2016). Under well-optimized RNase conditions, the protein-RNA 
complexes migrate on the gel diffusely above the apparent MW of the immunoprecipitated 
RBP, since the diverse sizes of RNA fragments variably affect the migration of the RBP-RNA 
complex. These complexes are then excised from the appropriate region of the membrane 
according to recommended guidelines (Huppertz et al., 2014; Ule et al., 2005), and the RBP 
is digested with proteinase K, which leaves only a short peptide at the crosslink site and 
releases the RNA fragments into solution. To prepare a cDNA library from these RNA 
fragments, the original CLIP protocol ligated a second adapter to the 5’ end of RNA 
fragments. This approach has been used when CLIP was first combined with high-
throughput sequencing (HITS-CLIP, Figure 1). With the HITS-CLIP protocol, it is important 
that the cDNAs read through the crosslink site during the reverse transcription in order to 
ensure that they contain both adapters, which is required for the amplification and 
sequencing of cDNAs. 
Primary variations in CLIP protocols 
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The first aspect that has been varied in the CLIP methods is the crosslinking of protein-RNA 
complexes. Most variants of CLIP expose cells or tissues to the UV-C wavelength (254 nm), 
a procedure that usually takes less than a minute with cells placed on ice (Ule et al. 2003) or 
frozen in liquid nitrogen. PAR-CLIP introduces a variation in the crosslinking strategy (Hafner 
et al. 2010), where live cells are pre-incubated for hours with photoactivatable 
ribonucleosides 4-thiouridine (4SU) or 6-thioguanosine (6SG), which label the RNA in vivo 
and enable protein-RNA crosslinking to be performed with UV-A wavelength (365 nm). A 
mass spectrometry study has compared this protocol to UV-C crosslinking to conclude that 
the efficiency of the two approaches is quite similar across all RBPs (Castello et al. 2012). 
The advantage of UV-A crosslinking is its decreased capacity to induce DNA damage as 
compared to UV-C, although in most CLIP experiments samples are chilled or frozen during 
~30 second long UV crosslinking and then immediately solubilized, so that biologic 
consequences of DNA damage are minimal.  The disadvantages of PAR-CLIP are its 
limitation to biological systems where the photoactivatable nucleosides can be efficiently 
incorporated, and its recommended use of >100 million cells (Danan, Manickavel, and 
Hafner 2016), while 1 million or less are used by standard variants of CLIP. Moreover, 
prolonged preincubation with 6SG or 4SU can cause cellular toxicity, including stress 
responses and inhibition of rRNA synthesis (Burger et al. 2013; Huppertz et al. 2014) and 
therefore care needs to be taken to monitor the cellular response to these ribonucleosides 
(Burger et al. 2013; Huppertz et al. 2014). 
For methods aimed at studying RNA methylation, it is also possible to use a mutant RNA 
methylase enzyme, which forms a covalent bond with RNA spontaneously without the need 
for UV-induced crosslinking, as has been done by m5C-miCLIP for transcriptome-wide 
mapping of 5-methylcytosine (m5C) modification sites (Sugimoto et al. 2012; Hussain et al. 
2013). Alternatively, proteins can be crosslinked to purified RNA with UV light in vitro. This 
has been exploited by protocols that crosslink an antibody that binds to a methylated base in 
order to study RNA methylation, such as m6A-CLIP (Chen et al. 2015; Ke et al. 2015; Linder 
et al. 2015) (Figure 1). The antibody-RNA complex is then captured on protein A/G magnetic 
beads, and the sample continues to the rest of the CLIP protocol. 
The second aspect of CLIP methods in which major variations have been explored involves 
ligating adaptors to the fragmented RNA. By modifying the ligation conditions, it is possible 
to enable proximity ligation of the two strands of RNA duplexes that are bound by double-
strand RNA binding proteins (dsRBPs). When the two strands get ligated, the resulting 
sequencing reads are referred to as ‘hybrid reads’, since they need to be split into two 
sequences that map to separate loci in the genome. This approach has been exploited to 
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study intermolecular duplexes, such as snoRNA-rRNA, mRNA-miRNA and lncRNA-mRNA, 
as well as intramolecular RNA-RNA duplexes bound by dsRBPs (Chi et al. 2009; Imig et al. 
2014; Kudla et al. 2011; Sugimoto et al. 2015; Moore et al. 2015). Further technical details of 
these protocols, their data analysis, and relationship to other methods to study RNA 
secondary structure are reviewed in more depth elsewhere (Sugimoto et al. 2017). 
A major advance in analysis of RNA structure was made with the development ligation 
conditions to allow hybrid CLIP (hiCLIP), which ligates the two RNA strands with an 
additional adaptor to gain control over the intermolecular ligation. This is achieved with the 
use of two types of RNA adaptors, which are ligated to RNA duplexes: RNA adaptor A with 
an irreversible 3’ block (dideoxynucleotide), and RNA adaptor B with an enzymatically 
removable 3’ block (phosphate). While the RNA duplexes remain bound to dsRBPs during 
IP, the two adaptors are first ligated in equimolar concentration, thus ~50% of the duplexes 
are expected to contain a different adaptor at each strand. The 3’ block of adaptor B is then 
removed, and the next ligation reaction is performed to ligate the two arms of RNA duplexes 
via the adaptor B. This results in hybrid reads that contain the two strands of RNA duplexes 
separated by the adaptor B, which allows unambiguous identification of the two arms of the 
hybrid reads. The method has been used to identify RNA duplexes bound by Staufen 1 in 
HEK293 cells, which identified intermolecular mRNA-mRNA and mRNA-lncRNA duplexes, in 
addition to RNA duplexes that connect complementary parts of the same RNA. In the coding 
sequence, these complementary parts were generally proximally located, while in UTRs they 
were more often located over 100 nts apart. Initial studies with a reporter assay indicated a 
role for such ‘long-range’ duplexes in the regulation of mRNA stability (Sugimoto et al. 2015), 
and their broader functional importance remains to be examined. 
The final major variations in CLIP involve the preparation of the cDNA library. Individual 
nucleotide CLIP (iCLIP) ligates the second adapter to the 3’ end of the cDNA via 
circularization (König et al. 2010). This enables amplification of cDNAs that prematurely 
truncate at the crosslinked nucleotide, in addition to the readthrough cDNAs, thus increasing 
the sensitivity of the method. 17 other published protocols similarly amplify truncated cDNAs, 
including BrdU CLIP, eCLIP and irCLIP (Van Nostrand et al. 2016; Zarnegar et al. 2016; 
Weyn-Vanhentenryck et al. 2014). In iCLIP and most other CLIP methods, additional 
sequences are part of the adapter oligonucleotide, including an experimental barcode that 
enables multiplexing of different experiments, and a unique molecular identifier (UMI) that 
enables quantification of unique cDNAs to remove the artefacts of variable PCR 
amplification (König et al., 2010) (Figure 1). Following adapter ligation, cDNAs are then 
10 
purified and amplified by PCR, which is achieved in multiple ways by variant protocols, as 
described in detail elsewhere (Lee and Ule 2018). 
CLIP data analysis 
The primary advantage of CLIP is that it allows investigators to narrow down the very large 
number of computationally possible binding sites for a given RBP to a smaller subset of sites 
with evidence of direct RBP contact in the relevant cell type.  This was clearly illustrated in 
the ability of Ago-miRNA-mRNA CLIP to identify true miRNA binding sites from among a 
larger set of computationally predicted sites, improving accuracy (Chi et al. 2009) and 
leading to unexpected discoveries (Chi, Hannon, and Darnell 2012; Moore et al. 2015; Luna 
et al. 2015).   
The first steps in analyzing CLIP sequencing data involve using the experimental barcodes 
to demultiplex the cDNA libraries, mapping the data to the genome, and identifying unique 
cDNAs with the use of UMIs, if available. Moreover, multiple methods can be used normalize 
the binding patterns relative to RNA abundance (Lee and Ule 2018). Depending on whether 
the protocol amplified truncated cDNAs or not, the peaks of RNA binding sites can be 
assigned in two primary ways. For HITS-CLIP and other protocols that only amplify 
readthrough cDNAs, the full position of mapped reads is examined. The most likely position 
of the crosslink site can be identified within a proportion of the reads by identifying 
crosslinking-induced mutation sites, such as C to T transitions when 4SU is used in PAR-
CLIP (Hafner et al. 2010), or deletions and other types of mutations in HITS-CLIP (C. Zhang 
and Darnell 2011). In iCLIP and 17 other protocols that amplify truncated cDNAs, crosslink 
sites are located at the start of these cDNAs. The truncated cDNAs strongly dominate the 
iCLIP libraries, and thus analysis of cDNA starts enables the nucleotide-resolution mapping 
of the crosslink sites, especially when combined with high-resolution peak-calling algorithms 
(Haberman et al. 2017; Sugimoto et al. 2012). The simplest peak-calling approach is to 
identify clusters of crosslinking events with cDNA counts that are significantly higher 
compared to randomized data in same genomic regions (König et al. 2010). 
While peak analysis of RBP-RNA binding sites has been of great value in understanding 
binding specificity and demarcating discrete points of regulation (Chakrabarti et al. 2017), 
not all regulatory factors have been shown to bind to individual discrete peaks. For example, 
hnRNP C binds widely across the transcriptome, with a periodicity suggesting the possibility 
of nucleosomal-like organization on RNA transcripts, which also reflects its binding to the 
dual U-rich sequences in antisense Alu elements (König et al. 2010; Zarnack et al. 2013).  
FMRP, the protein lost in the commonest inherited form of intellectual disability, the Fragile-X 
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Syndrome, was found by CLIP to bind to a subset of transcripts across their entire coding 
length (J. C. Darnell et al. 2011).  This was then shown to result from dual interactions of 
FMRP with the ribosome and the mRNA to cause ribosomal elongation arrest and 
translational pausing on its target transcripts. In such instances, more complex 
computational modelling may be needed in addition to peak analysis to understand how the 
RBPs recognize specific target RNAs. 
Paralleling the genomic mapping and peak assignment, an essential concomitant is to 
examine the quality of data. Analysis of negative controls is particularly important for 
interpreting the data specificity. For example, purification can be performed from cells where 
the RBP is absent, such as knockout cells, or when using tag-based purification, cells that 
do not express a tagged protein. As an alternative, non-specific serum or IgG can be used 
for IP, or the RBP can be purified from non-crosslinked cells. Ideally, these controls should 
not produce any clearly detectable signal during SDS-PAGE analysis, and the number of 
unique cDNAs in their resulting libraries should be at least 100-fold fewer than in the specific 
experiments (König et al. 2010). 
The sensitivity and specificity of data can be further examined by assessing the total number 
of unique cDNAs in the sequencing library and the peaks, respectively. To monitor the 
specificity of CLIP, a suitable peak-calling program needs to be chosen according to the 
CLIP protocol used to produce the data (Chakrabarti et al. 2017). A low number of peaks 
indicates either that the cDNAs are dispersed along the transcripts, or that they are 
concentrated in a small number of abundant RNAs (such as rRNA) – this could either reflect 
low preference of the RBPs for specific sites on longer RNAs, or low quality of data. Thus, 
some understanding of the expected binding properties of the RBP can help when 
interpreting CLIP data.  
Finally, an extremely informative way to examine CLIP data sensitivity and specificity is to 
assess binding peaks with orthogonal data in the format of RNA maps (Donny D. Licatalosi 
and Darnell 2010; D. D. Licatalosi et al. 2008), which allow the investigator to examine if 
binding is enriched at exons or mRNAs that are differentially regulated by the RBP. Analysis 
of crosslink peaks in the format of RNA maps is particularly valuable when comparing 
multiple datasets for the same RBP. For example, data produced by iCLIP of PTBP1 led to a 
larger number of peaks around regulated exons than data produced by other protocols, even 




A major forefront in biological research is to understand the functional roles of individual cell 
types in a multicellular organism. Cell-type specific regulation of RNA expression and 
processing emerges as a common phenomenon from recent RNA profiling studies in 
selected cell populations (X. Zhang et al. 2016; Yap et al. 2016; Bhate et al. 2015). 
Importantly, it is clear from these studies that many cell-type specific RNA regulatory events 
are not identifiable in whole tissue analysis. Therefore, developing new technologies with 
cell-type resolutions is critical to advance our understanding of cell-type specific RNA 
regulation. 
  
To meet the challenge of applying CLIP to study cell-type specific biology, we developed the 
conditionally-tagged (cTag) CLIP technology, which utilizes a genetically engineered mouse 
that carries a latent GFP-tagged allele of the RNA-binding protein (RBP) of interest. The 
latent GFP-tagged allele is “off” by default, leaving the native allele unaffected, and only 
turns “on” in the presence of Cre recombinase (Figure 2A) (Hwang et al. 2017). Importantly, 
the GFP-tagged allele is expressed by homologous recombination into the endogenous 
locus, such that the quantitative, qualitative (alternate isoforms), spatial and temporal 
expression of GFP-tagged RBP is minimally disruptive to the biology of the system, and can 
be precisely controlled through Cre expression to achieve cell-type specificity. Cell-type 
specific CLIP analysis for the RBP of interest is then be performed using a mix of high 
affinity GFP antibodies to immunoprecipitate the GFP-tagged RBPs under stringent 




Figure 2: cTag-CLIP 
A) The basic design of a cTag mouse. An extra copy of the last coding exon fused with GFP 
sequence (green) is inserted downstream of sequences encoding the RNA-binding protein of 
interest. To prevent read-through, triple poly(A) sites (3XpA) are inserted before the GFP-
tagged exon. Cre-mediated excision of the endogenous last exon results in expression of 
GFP-tagged RBP from its native locus. Arrowheads: loxP sites. B) Illustrative examples of 




The cTag-CLIP technology has several important features to ensure a proper representation 
of endogenous RNA-protein interactions but at the same time to maintain a broad 
applicability. First, since cTag mice are created using a “knock-in” approach, the proper 
cellular expression of RBPs and the RNA-RBP stoichiometry is likely to be maintained, both 
of which are difficult to achieve with either traditional or even bacterial artificial chromosome 
(BAC) transgenes (He et al. 2012; Gerfen, Paletzki, and Heintz 2013) (Figure 2A). Second, 
the utilization of a mix of high affinity GFP antibodies (Heiman et al. 2014) allows cTag-CLIP 
analysis to be performed with a standardized and optimized high stringency protocol for 
different RBPs (Hwang et al. 2017). The standardization eliminates the need for RBP-
specific antibodies and the subsequent experimental optimization to achieve high stringency 
immunoprecipitation for individual RBPs. Furthermore, it also provides an equal footing for 
cross-comparison of cTag-CLIP data from different RBPs to facilitate data integration. Third, 
its compatibility with the Cre/Lox system allows direct application of existing or newly 
developed Cre mouse lines, which makes it a versatile tool for wide-ranging biological 
investigations. 
  
We have since successfully established a series of cTag mice to perform cTag-CLIP 
analysis for different RBPs in multiple cell types. We validated this approach using 
conditionally tagged poly(A)-binding protein (PABP; gene symbol: Pabpc1) to generate the 
cTag-PABP mouse and to establish the cTag-PAPERCLIP technique (Hwang et al. 2017). 
cTag-PAPERCLIP utilizes PABP as a biological filter to specifically clone distal mRNA 3′ 
ends to generate comprehensive mRNA alternative polyadenylation (APA) maps. With cTag-
PAPERCLIP, we performed an in-depth APA analysis in individual cell types in vivo in adult 
mouse brain to demonstrate the dynamics of APA regulation and discovered a previously 
unknown role of APA in diversifying protein expression in the brain. 
  
Several observations from this cTag-PAPERCLIP study exemplify the technical advances 
and, more importantly, biological implications of the cTag-CLIP technology, which are 
detailed below. 
  
1. cTag-CLIP achieves desired cell-type specificity to provide a powerful means 
to dissect cell-type specific biology: The ubiquitous expression of PABPC1 presents an 
ideal test case for the capabilities of cTag-CLIP technology in achieving high cell-type 
specificity. To evaluate the cell-type specificity at the anatomical level, we examined the 
expression patterns of PABP-GFP in brains from four mouse models generated by crossing 
the cTag-PABP mouse to four Cre drivers with different cell-type specificity (excitatory 
neurons, inhibitory neurons, astrocytes and microglia (Figure 2B)). The analyses indeed 
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confirmed the distinct expression patterns of PABP-GFP from the four mouse models and 
their consistency with the corresponding cell-type markers. Next, we evaluated the cell-type 
specificity at the molecular level by analyzing the four resulting RNA profiles from each 
mouse model generated by cTag-PAPERCLIP. These cTag-PAPERCLIP profiles correlated 
with independently generated cell-type specific RNA-seq profiles and showed expected 
segregation of known cell-type specific marker genes by the Cre activities. Overall, these 
data demonstrate that cTag-CLIP indeed accomplishes its goals: 1) specific expression of 
the tagged RBP in the desired cell populations and 2) generation of cell-type specific CLIP 
maps. Importantly, cTag-CLIP data obtained from cTag mouse models are very consistent 
with data generated in wild-type mouse through a variety of methods in multiple occasions 
(Saito et al. 2018; Hwang et al. 2017; Jereb et al. 2018), showing that cTag-CLIP approach 
in general does not interfere with normal RBP biology and hence provides a powerful means 
for dissecting cell-type specific biology. 
  
2. cTag-CLIP has excellent power to “zoom in” on less abundant cell-types to 
discover cell-type specific regulatory events: Our in-depth cTag-PAPERCLIP analysis of 
APA patterns across four major brain cell types and between different cellular states in 
microglia (quiescent vs. activated) revealed novel cell-type specific regulatory events. For 
example, we demonstrated that cell-type specific RBPs directly shape the distinct APA 
patterns of Itsn1, Map4 and Cdc42 between neurons and glia/non-neural tissues. Moreover, 
in activated microglia, we identified that Araf switches from a truncated APA isoform (which 
generates a kinase-deficient protein) to a full-length APA isoform (which generates a kinase-
intact protein). Importantly, these findings nicely illustrate how gaining resolution at the cell-
type level allows cTag-CLIP to generate new biological insights as these four genes are 
expressed in multiple cell types in the brain and it would be difficult for whole tissue analysis 
to pick up these cell-type specific regulatory events. 
   
3. cTag-CLIP well-preserves native transcriptome states and has an advantage in 
profiling sensitive cell types: One distinctive feature of cTag-CLIP is its “built-in” cell-type 
specificity imparted through genetic expression of cell-type restricted Cre in cTag mice 
(Figure 2B). As a result, cTag-CLIP can utilize the whole tissue as the input material without 
going through the process of tissue dissociation and cell-type purification, which is 
necessary for common RNA profiling methods such as RNA-seq to achieve cell-type 
specificity. Tissue dissociation and cell-type purification disrupts the tissue 
microenvironment, causes cellular stress and may alter gene expression (Cardona et al. 
2006; Okaty, Sugino, and Nelson 2011). Most importantly, cTag-CLIP kept the expression of 
microglia activation markers and immediate early genes (which respond to cellular stress) 
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low compared with RNA-seq profiling from ex vivo purified microglia. These results 
demonstrate that cTag-CLIP better preserves native transcriptome states of individual cell 
types and therefore is suitable for accurate in vivo RNA profiling. 
 
The success of our initial cTag-CLIP studies starts to reveal a diversity of RNA regulatory 
events in individual cell-types. Generation and integration of cTag-CLIP maps for different 
RBPs in multiple cells types will provide essential information to refine the existing rules of 
RNA-protein interaction for individual cell-types. Importantly, with the cTag-CLIP maps, it is 
now feasible to deduce the cooperative and/or competitive interactions among different 
RBPs for the same RNA binding sites in a single cell-type to construct high-order RNA-
protein interaction maps. Recent improvement in generating knock-in mouse models from 
advances in synthetic biology and gene-targeting technology will speed up the process of 
expanding the cTag mice repertoire (Shalem, Sanjana, and Zhang 2015; Wright, Nuñez, and 
Doudna 2016). Moreover, continued identification of cell-type specific markers and technical 
advancement enhancing the sensitivity of CLIP technique will broaden the application of 
cTag-CLIP to new and rare cell types (Tasic et al. 2016; Lee and Ule 2018). 
 
Insights from CLIP and Future Directions 
The development of CLIP has been driven largely by the need to understand the regulation 
of pre-mRNA processing, although it can be applied to all forms of post-transcriptional RNA 
regulation, including translation as demonstrated with CLIP studies of FMRP. For studies of 
pre-mRNA, it is crucial to map the binding of nuclear RBPs to introns, which are generally of 
low abundance and of transient nature. To allow studies of RBP interactions on introns, 
specificity of the method had to be maximized, which led to the inclusion of covalent 
crosslinking followed by several stringent purification and quality control steps. While the 
success of this approach was demonstrated by the very first studies of Nova, CLIP also led 
to an unexpected finding that nuclear RBPs have many thousands of high-affinity binding 
sites, most of which are far from exons (Ule et al. 2003; D. D. Licatalosi et al. 2008). In 
recent years, it has become clear that many abundant nuclear RBPs, such as hnRNPC, 
often bind to specific transposable elements or other repetitive sequences that are present in 
introns, where they repress processing of cryptic exons and polyadenylation sites (Zarnack 
et al. 2013; Sibley, Blazquez, and Ule 2016). While this repressive binding safeguards the 
transcriptome from newly-emerging intronic sites of RNA processing, it may also create an 
opportunity for a gradual evolutionary emergence of new alternative exons upon mutations 
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that weaken the repressive binding (Attig et al. 2016). Thus, even though the large number 
of intronic binding sites of nuclear RBPs initially came as a surprise, it is becoming clear that 
this plays an important role in the control of rarely included cryptic exons, including those 
mediating nonsense mediated decay (Eom et al. 2013), and in the evolution of gene 
expression (Sibley, Blazquez, and Ule 2016). 
Molecular and Physiologic Insights from CLIP 
Following identification of in vivo binding sites, further integration with orthogonal functional 
data can then allow interpretation of regulatory mechanisms that operate in cells and organs. 
For example, the integrative approach to examine binding profiles around regulated exons 
and polyadenylation sites has been visualized in the form of RNA maps (Ule et al. 2006; 
Witten and Ule 2011; D. D. Licatalosi et al. 2008). This union of biochemical CLIP data with 
functional evidence via the bioinformatic generation of global “RNA maps” led to the 
recognition that the position of protein binding sites in transcripts provided information 
relevant to their mechanisms and regulatory outcomes (Ule et al. 2003; D. D. Licatalosi et al. 
2008).  For example, it revealed that nuclear RBPs often regulate splicing and 3’ processing 
via similar positional principles, with repressive binding located close to the sites of RNA 
processing, and enhancing binding located further downstream (D. D. Licatalosi et al. 2008; 
Rot et al. 2017). The insights from such analysis can complement predictive programs such 
as TargetScan, which predicts possible binding sites for miRNAs by incorporating 
information on evolutionary conservation and general binding rules; for example, CLIP could 
identify important miRNA binding sites that are unique to human (Chi et al. 2009) or are 
located at non-canonical sequences that don’t conform to general rules (Chi, Hannon, and 
Darnell 2012; Moore et al. 2015). 
Many studies have shown that RNP assembly on the nascent and mature mRNA, and the 
resulting regulatory mechanisms are coordinated at many levels (Singh et al. 2015), and 
CLIP has solidified these observations.  Many RBPs shuttle between nucleus and 
cytoplasm, which allows mRNP assembly to start in the nucleus on pre-mRNAs and then 
continue to influence cytoplasmic regulation. For example, while CLIP identified roles for 
Nova proteins in nuclear pre-mRNA processing (Ule et al. 2003; D. D. Licatalosi et al. 2008), 
it also revealed 3’ UTR binding sites in the vicinity of factors involved in alternative 
polyadenylation; again using genetics, such binding was found to be functional in 
determining the use of APA sites (Ule et al. 2003; D. D. Licatalosi et al. 2008).  Moreover, 
CLIP, together with immuno-EM localization of Nova in the dendrite, identified a new link 
between nuclear regulation and synaptic RNA localization within neurons (Racca et al. 
2010). This demonstrated that an RNA regulatory factor was governed by its binding affinity 
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to motifs that can be located at various positions in the transcriptome, and that a mammalian 
splicing factor could also bind and regulate mature mRNA biology. 
Biologically, some of the more powerful conclusions from CLIP biochemistry have come from 
pairing it with genetic manipulations.  CLIP studies have been most definitive in vivo in mice 
where individual (R. B. Darnell 2013) and more recently multiple (Saito et al. 2018) RBPs 
have been genetically deleted.  Similarly, CLIP studies have been successful in tissue 
culture cells where RBPs have been knocked down.  Such genetic studies have been 
complemented by genetic rescue experiments. This was illustrated in early studies 
demonstrating the requirement of Nova for splicing of the  Z+ isoform of the agrin gene in 
motor neurons (Ule et al. 2005), and as a result the Nova1 KO mice have abnormal 
neuromuscular junctions and are paralyzed (Ruggiu et al. 2009). Moreover, Nova proteins 
regulate an alternative exon in Dab1 (Ule et al. 2006), an important regulator of reelin 
signaling in newly born migrating neurons (Yano et al. 2010). Importantly, specific 
phenotypes of Nova KO mice can be rescued by expressing the appropriately spliced 
isoform; interestingly, when this was done by mating Nova1 KO mice to transgenic mice 
constitutively expressing Z+ agrin, the normal neuromuscular junction was re-established, 
but the mice remained paralyzed, illustrating the multi-layered aspect of RBP-RNA regulation 
in vivo (Ruggiu et al. 2009). Beyond studies of Nova, CLIP has been successfully applied to 
characterize the function and assembly of many additional disease-relevant RBPs in the 
brain and other tissues of model organisms (Modic, Ule, and Sibley 2013; R. B. Darnell 
2013).  
CLIP: Future Directions 
One of the most recent applications of CLIP has been to undertake studies of epigenetic 
modifications of RNA.  These were pioneered with studies of m6A RNA modifications, using 
a variant of CLIP in which the modified nucleotide itself was directly crosslinked, in vitro, to 
m6A specific antibodies (Ke et al. 2015; Linder et al. 2015; Patil, Pickering, and Jaffrey 
2018). This provides a potentially general strategy for analyzing what is an expanding 
number of post-transcriptional RNA modifications important in cell function and human 
disease (Jonkhout et al. 2017).  
The same general principles of CLIP experiments apply in analyses of RNA modifications as 
in traditional CLIP: unbiased, genome-wide genetic studies allow demarcation of specific 
sites, here using direct modification-specific antibodies to crosslink the modified RNA 
nucleotide.  For example, m6A CLIP was used to identify terminal exons as the most 
common positions for m6A modification on RNA transcripts, rather than exons harboring 
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stop codons (Ke et al. 2015); to demonstrate primary functions of m6A in RNA turnover 
rather than regulation of alternative splicing (Ke et al. 2017); and to clarify our current 
understanding of the biologic role of m6A RNA modifications (Ke et al. 2017; R. B. Darnell, 
Ke, and Darnell 2018). 
Importantly, CLIP has been shown to be of value also for studies of human postmortem 
tissues (Tollervey et al. 2011). This is important as such tissues are often frozen in liquid 
nitrogen.  RNA-protein complexes appear to survive such conditions well, and allow CLIP to 
be applied to tissues relevant for a range of human disease (e.g., cancer, immunologic or 
neurologic disease) using a range of human tissue (tumor (Vanharanta et al. 2014), blood 
(Loeb et al. 2012) and brain (Tollervey et al. 2011; Scheckel et al. 2016), respectively). The 
value of CLIP has also been demonstrated to unravel the dynamics of RNPs under disease 
conditions by comparing tissue from disease patients and controls (Tollervey et al. 2011), or 
monitoring the impact of viral infection on host transcripts in biology and human disease 
(Flynn et al. 2015; Luna et al. 2015, 2017; Moore et al. 2018). 
Demarcation of RNA structure using CLIP was originally pioneered with hiCLIP to analyze 
Staufen-RNA interactions (Sugimoto et al. 2015), and subsequently developed with a variety 
of complementary approaches such as PARIS (psoralen analysis of RNA interactions and 
structures)  (Lu, Gong, and Zhang 2018; Lu et al. 2016) as discussed above.  Such analyses 
are important in their own right, and in their potential to allow more general understanding of 
structures accessible to RBP regulation, as determined from CLIP analyses. The combined 
understanding of protein-binding sites, RNA structure and evolutionary constraints promises 
to expand our ability to predict genetic variants using Bayesian (C. Zhang et al. 2010) and 
machine-learning tools (Barash et al. 2010), and ultimately apply such understanding to 
interpretation of those variants that have impact on disease phenotypes. 
Since the very initial development of CLIP, a common theme of many CLIP studies has been 
that they combine discovery of fundamental mechanisms of gene regulation along with 
biologic and clinically relevant insights.  CLIP holds great promise for studies aimed at 
defining the functionally important RNA sites across the transcriptome, unravelling the 
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